NSAIDs are contraindicated in asthma as they inhibit cyclooxygenase (COX) and reduce prostaglandin synthesis.
The inhibition of the COX pathway activates the lipoxygenase pathway which leads to increase leukotrienes synthesis.
Leukotrienes will increase risk of bronchospasm or occurrence of asthma.